|
Molecular characterization of pancreatic cancers as seen in the SLUG gene revealing cancer progression. |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Caris Life Sciences |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Caris Life Sciences |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Caris Life Sciences; ImaginAb; TransTarget |
Speakers' Bureau - Caris Life Sciences |
Research Funding - Astellas Pharma; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Biomedical; Caris Life Sciences; Daiichi Sankyo; Eisai; Esperas Pharma; Esperas Pharma; Exelixis; Five Prime Therapeutics; H3 Biomedicine; Halozyme; ImaginAb; Incyte; Inovio Pharmaceuticals; Lexicon; LSK BioPharma; MSK Pharma; Nouscom; Plexxikon; Taiho Pharmaceutical; Torque; Xencor |
Travel, Accommodations, Expenses - Caris Life Sciences; GE Healthcare; ImaginAb; Inovio Pharmaceuticals; TransTarget |
|
|
|
Consulting or Advisory Role - Merck; Novartis; Taiho Pharmaceutical |
Expert Testimony - Genentech/Roche; Taiho Pharmaceutical |
Travel, Accommodations, Expenses - Amgen; Merck; Merck KGaA |
|
|
Honoraria - Onclive; Rafael Pharmaceuticals; Tempus |
Consulting or Advisory Role - Bayer |
Speakers' Bureau - Bayer; HalioDx; Lilly; Sirtex Medical; Taiho Pharmaceutical |
Research Funding - Abbvie (Inst); Ipsen (Inst); Isofol Medical (Inst); Novartis (Inst) |
Expert Testimony - AstraZeneca |
Travel, Accommodations, Expenses - Boehringer Ingelheim; Caris Life Sciences |
|
|
Honoraria - Boston Scientific; GlaxoSmithKline; Novocure |
Consulting or Advisory Role - Boston Scientific; Novocure; Novocure; Novocure; Novocure |
Research Funding - Novocure |
Travel, Accommodations, Expenses - GlaxoSmithKline |
(OPTIONAL) Uncompensated Relationships - Minnetronix Medical; NomoCan |
|
|
Honoraria - Foundation Medicine |
Consulting or Advisory Role - Ability Pharma; Perthera |
Speakers' Bureau - Incyte |
Research Funding - Amgen (Inst); Apexigen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Genentech (Inst); Incyte (Inst); Rafael Pharmaceuticals (Inst) |
|
|
Research Funding - Ambry Genetics; AstraZeneca; Caris Life Sciences; Foundation Medicine; InVitae; Myriad Genetics |
Patents, Royalties, Other Intellectual Property - I share a patent with several Fox Chase investigators for a novel method to investigate hereditary CRC genes (Inst) |
Travel, Accommodations, Expenses - AstraZeneca; Caris Life Sciences; Foundation Medicine; Myriad Genetics |
Other Relationship - Caris Life Sciences; Foundation Medicine; Invitae; Myriad Genetics |
|
|
Consulting or Advisory Role - Caris Life Sciences |
Travel, Accommodations, Expenses - Caris Life Sciences |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - Caris Life Sciences; Indivumed |
Honoraria - Amgen; Bayer/Onyx; Caris Life Sciences; Celgene; Genentech/Roche; Merck; Taiho Pharmaceutical |
Consulting or Advisory Role - Amgen; Bayer/Onyx; Caris Life Sciences; Celgene; Genentech/Roche; Taiho Pharmaceutical |
Speakers' Bureau - Amgen; Bayer/Onyx; Celgene; Genentech/Roche; Merck; Taiho Pharmaceutical |
Research Funding - Amgen (Inst); Bayer/Onyx (Inst); Boehringer Ingelheim (Inst); Genentech/Roche (Inst); MedImmune (Inst); Pfizer (Inst) |
|
|
No Relationships to Disclose |
|
|
Honoraria - Bayer; Boehringer Ingelheim; GlaxoSmithKline; Isofol Medical; Merck Serono; Roche |
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Merck Serono; Roche |
Travel, Accommodations, Expenses - Bayer; Merck Serono |